Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study
- 10 October 2019
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 42 (11), 2042-2049
- https://doi.org/10.2337/dc19-0401
Abstract
OBJECTIVE The long-term outcome of allogenic islet transplantation is unknown. The aim of this study was to evaluate the 10-year outcome of islet transplantation in patients with type 1 diabetes and hypoglycemia unawareness and/or a functioning kidney graft. RESEARCH DESIGN AND METHODS We enrolled in this prospective parallel-arm cohort study 28 subjects with type 1 diabetes who received islet transplantation either alone (ITA) or after a kidney graft (IAK). Islet transplantation consisted of two or three intraportal infusions of allogenic islets administered within (median [interquartile range]) 68 days (43–92). Immunosuppression was induced with interleukin-2 receptor antibodies and maintained with sirolimus and tacrolimus. The primary outcome was insulin independence with A1C ≤6.5% (48 mmol/mol). Secondary outcomes were patient and graft survival, severe hypoglycemic events (SHEs), metabolic control, and renal function. RESULTS The primary outcome was met by (Kaplan-Meier estimates [95% CI]) 39% (22–57) and 28% (13–45) of patients 5 and 10 years after islet transplantation, respectively. Graft function persisted in 82% (62–92) and 78% (57–89) of case subjects after 5 and 10 years, respectively, and was associated with improved glucose control, reduced need for exogenous insulin, and a marked decrease of SHEs. ITA and IAK had similar outcomes. Primary graft function, evaluated 1 month after the last islet infusion, was significantly associated with the duration of graft function and insulin independence. CONCLUSIONS Islet transplantation with the Edmonton protocol can provide 10-year markedly improved metabolic control without SHEs in three-quarters of patients with type 1 diabetes, kidney transplanted or not.Keywords
This publication has 43 references indexed in Scilit:
- Oestrogens improve human pancreatic islet transplantation in a mouse model of insulin deficient diabetesDiabetologia, 2012
- Reduced Progression of Diabetic Microvascular Complications With Islet Cell Transplantation Compared With Intensive Medical TherapyTransplantation, 2011
- Primary Graft Function, Metabolic Control, and Graft Survival After Islet TransplantationDiabetes Care, 2009
- Long-Term Insulin-Independence After Allogeneic Islet Transplantation for Type 1 Diabetes: Over the 10-Year MarkAmerican Journal of Transplantation, 2009
- Intraperitoneal Insulin Infusion Versus Islet Transplantation: Comparative Study in Patients with Type 1 DiabetesTransplantation, 2009
- A Multi-Year Analysis of Islet Transplantation Compared With Intensive Medical Therapy on Progression of Complications in Type 1 DiabetesTransplantation, 2008
- Changes in Renal Function after Clinical Islet Transplantation: Four-Year Observational StudyAmerican Journal of Transplantation, 2007
- β-ScoreDiabetes Care, 2005
- Islet Transplantation Is Associated with Improvement of Renal Function among Uremic Patients with Type I Diabetes Mellitus and Kidney TransplantsJournal of the American Society of Nephrology, 2003
- Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation1Transplantation, 2003